Pelvic inflammatory disease associated with Chlamydia trachomatis but not Mycoplasma genitalium in New Zealand
Jeannie Oliphant A B and Sunita Azariah A
+ Author Affiliations
- Author Affiliations
A Auckland Sexual Health Service, Greenlane Clinical Centre, Private Bag 92024, Auckland 1142, New Zealand.
B Corresponding author. Email: jeannieo@adhb.govt.nz
Sexual Health 13(1) 43-48 https://doi.org/10.1071/SH14238
Submitted: 15 December 2014 Accepted: 7 September 2015 Published: 9 November 2015
Abstract
Background: There is a paucity of studies looking at associations between Mycoplasma genitalium and pelvic inflammatory disease (PID). The objectives of this study were to estimate the prevalence of M. genitalium in women attending a sexual health service in New Zealand and secondly to examine for an association of M. genitalium with PID. Methods: Women consecutively attending the service for a sexual health screen (Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis) were recruited to establish a baseline prevalence of M. genitalium. An extra cervical swab was taken for the detection of M. genitalium. Recruitment of additional women with a clinical diagnosis of PID continued until a sufficient sample size was obtained to examine the association of PID with M. genitalium. Women in the baseline sample without PID were used as the control group. Results: The control group included 250 women, with M. genitalium diagnosed in 8.7% (95% CI 5.8–12.9%) and C. trachomatis in 9.9% (95% CI 6.8–14.2%). Ninety-one women were recruited with PID; M. genitalium was diagnosed in 9.9% (95% CI 5.3–17.7%) and C. trachomatis in 27.5% (95% CI 19.4–37.4%). Multivariate analysis using clinically relevant variables showed that a diagnosis of C. trachomatis (OR 2.44, 95% CI 1.24–4.81) but not M. genitalium (OR 0.91, 95% CI 0.38–2.20) was significantly associated with a PID diagnosis. Conclusions: M. genitalium was almost as commonly diagnosed as C. trachomatis in this population. C. trachomatis was the only infection that was significantly associated with PID.
References
[1] Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from chrysalis to multicoloured butterfly. Clin Microbiol Rev 2011; 24 498–514.| Mycoplasma genitalium: from chrysalis to multicoloured butterfly.Crossref | GoogleScholarGoogle Scholar | 21734246PubMed |
[2] Lusk MJ, Konecny P, Naing ZW, et al Mycoplasma genitalium is associated with cervicitis and HIV infection in an urban Australian STI clinic population. Sex Transm Infect 2011; 87 107–9.
| Mycoplasma genitalium is associated with cervicitis and HIV infection in an urban Australian STI clinic population.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC3M3gs1Cksg%3D%3D&md5=7a12b0b12212d7b821f7962c2a945893CAS | 21071566PubMed |
[3] Anagrius C, Loré B, Jensen JS. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect 2005; 81 458–62.
| Mycoplasma genitalium: prevalence, clinical significance, and transmission.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2MnksleitA%3D%3D&md5=8585ead6df9b3906a698c5d649c90d29CAS | 16326846PubMed |
[4] Moi H, Reinton N, Moghaddam A. Mycoplasma genitalium in women with lower genital tract inflammation. Sex Transm Infect 2009; 85 10–4.
| Mycoplasma genitalium in women with lower genital tract inflammation.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1M%2Fos12hsg%3D%3D&md5=4f31fca35eefb2096415e07b6a50ba0aCAS | 18842689PubMed |
[5] Manhart LE, Mostad SB, Baeten JM, et al High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix. J Infect Dis 2008; 197 733–6.
| High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix.Crossref | GoogleScholarGoogle Scholar | 18266605PubMed |
[6] Hogdahl M, Kihlstrom E. Leucocyte esterase testing of first-voided urine and urethral and cervical smears to identify Mycoplasma genitalium – infected men and women. Int J STD AIDS 2007; 18 835–8.
| Leucocyte esterase testing of first-voided urine and urethral and cervical smears to identify Mycoplasma genitalium – infected men and women.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2sjjs1Kltw%3D%3D&md5=0c8ae3f9c5605c52d9199b69a8498721CAS | 18073017PubMed |
[7] Taylor-Robinson D, Furr PM, Tully JG, et al Animal models of Mycoplasma genitalium urogenital infection. J Med Sci 1987; 23 561–4.
| 1:STN:280:DyaL1c%2Fjt1ahug%3D%3D&md5=fe52b78bb126e55c65f1b28b94c8f6c0CAS |
[8] Haggerty CL, Totten PA, Astete SG, Ness RB. Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. Infect Dis Obstet Gynecol 2006; Article ID 30184
| Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease.Crossref | GoogleScholarGoogle Scholar |
[9] Cohen CR, Manhart LE, Bukusi EA, et al Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359 765–6.
| Association between Mycoplasma genitalium and acute endometritis.Crossref | GoogleScholarGoogle Scholar | 11888591PubMed |
[10] Cohen CR, Mugo NR, Astete SG, et al Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis. Sex Transm Infect 2005; 81 463–6.
| Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2MnksleitQ%3D%3D&md5=ecf5022413242cbb8152a0a6593730b4CAS | 16326847PubMed |
[11] Taylor-Robinson D, Jensen JS, Svenstrup H, et al Difficulties experienced in defining the microbial cause of pelvic inflammatory disease. Int J STD AIDS 2012; 23 18–24.
| Difficulties experienced in defining the microbial cause of pelvic inflammatory disease.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC383mtVSmsg%3D%3D&md5=a39fbb72a8bf4c623b5b8d12c6fc07ceCAS | 22362682PubMed |
[12] Oliphant J, Azariah S. Cervicitis: limited clinical utility for the detection of Mycoplasma genitalium in a cross-sectional study of women attending a New Zealand sexual health clinic. Sex Health 2013; 10 263–7.
| 23702105PubMed |
[13] Lusk MJ, Konecny P. Cervicitis: a review. Curr Opin Infect Dis 2008; 21 49–55.
| 18192786PubMed |
[14] Ross J, McCarthy GUK. National guideline for the management of pelvic inflammatory disease. Cheshire: British Association for Sexual Health and HIV; 2011. Available online at: http://www.bashh.org [verified 8 December 2014].
[15] Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29 297–301.
| 1:STN:280:DyaK3M7nvVSmsQ%3D%3D&md5=192933c2ea8f9734c6159640e7d271feCAS | 1706728PubMed |
[16] Twin J, Taylor N, Garland SM, Hocking JS, Walker J, et al Comparison of two Mycoplasma genitalium real-time PCR detection methodologies. J Clin Microbiol 2011; 49 1140–2.
| Comparison of two Mycoplasma genitalium real-time PCR detection methodologies.Crossref | GoogleScholarGoogle Scholar | 21209170PubMed |
[17] Lawton BA, Rose SB, Bromhead C, Gaitanos LA, MacDonald EJ, Lund KA. High prevalence of Mycoplasma genitalium in women presenting for termination of pregnancy. Contraception 2008; 77 294–8.
| High prevalence of Mycoplasma genitalium in women presenting for termination of pregnancy.Crossref | GoogleScholarGoogle Scholar | 18342654PubMed |
[18] McGowin CL, Anderson-Smits C. Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women. PLoS Pathog 2011; 7 e1001324
| Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXntVajsrs%3D&md5=fab91b006198736d566a92df3023691fCAS | 21637847PubMed |
[19] Simms I, Eastick K, Mallinson H, et al Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease. Sex Transm Infect 2003; 79 154–6.
| Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3s7ntFyksg%3D%3D&md5=5275e4ce0a44222c00e9cf7bb60727ceCAS | 12690141PubMed |
[20] Oakeshott P, Aghaizu A, Hay P, et al Is Mycoplasma genitalium in women the “new Chlamydia?” A community-based prospective cohort study. Clin Infect Dis 2010; 51 1160–6.
| Is Mycoplasma genitalium in women the “new Chlamydia?” A community-based prospective cohort study.Crossref | GoogleScholarGoogle Scholar | 20942656PubMed |
[21] Bjartling C, Osser S, Persson K. The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy. BJOG 2010; 117 361–4.
| The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXitFGisr8%3D&md5=e19a92df8922017cf088340ab78d79b0CAS | 20015303PubMed |
[22] Bjartling C, Osser S, Persson K. Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynaecologic outpatient service. Am J Obstet Gynecol 2012; 206 476.e1–e8.
| Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynaecologic outpatient service.Crossref | GoogleScholarGoogle Scholar |
[23] Doxanakis A, Hayes RD, Chen MY, et al Missing pelvic inflammatory disease? Substantial differences in the rate in which doctors diagnose PID. Sex Transm Infect 2008; 84 518–23.
| Missing pelvic inflammatory disease? Substantial differences in the rate in which doctors diagnose PID.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD1cjot1yisg%3D%3D&md5=c51b7d697f30cc803c0aaae0d882c5eeCAS | 18723585PubMed |
[24] Jensen JS, Bradshaw CS, Tabrizi SN, et al Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008; 47 1546–53.
| Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1MXjs1Ohsw%3D%3D&md5=ea71fad9e791f7faba4d20521dfd85a1CAS | 18990060PubMed |
[25] Anagrius C, Loré B, Jensen JS. Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. PLoS One 2013; 8 e61481
| Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXmtlSmu7s%3D&md5=9d183370c2a3257e26e513bd04543dd0CAS | 23593483PubMed |
[26] Manhart LE, Broad JM, Golden MR. Mycoplasma genitalium: should we treat and how? Clin Infect Dis 2011; 53 S129–42.
| Mycoplasma genitalium: should we treat and how?Crossref | GoogleScholarGoogle Scholar | 22080266PubMed |
[27] Pond M, Nori AV, Witney AA, et al High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis. The need for routine testing and the inadequacy of current treatment options. Clin Infect Dis 2014; 58 631–7.
| High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis. The need for routine testing and the inadequacy of current treatment options.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2cXislersrY%3D&md5=51b61e8d1886a6ae9f46ce524b14d98eCAS | 24280088PubMed |
